SNORD31A: A Protein Regulating Brain Synaptic Plasticity (G9298)

Target Name: SNORD31

NCBI ID: G9298

SNORD31

Other Name(s): SNORD31A | Small nucleolar RNA, C/D box 31 | small nucleolar RNA, C/D box 31 | RNU31 | U31

SNORD31A: A Protein Regulating Brain Synaptic Plasticity

SNORD31 (SNORD31A) is a protein that is expressed in the brain and is known for its role in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. The study of SNORD31A and its role in synaptic plasticity has led to the possibility that it may be a drug target or biomarker.

Synaptic plasticity is the ability of the brain to change and adapt over time. It is a critical aspect of the brain's development and function, as it allows the brain to learn and adapt to new experiences and environments. SNORD31A is a protein that is expressed in the brain and is known to play a role in the regulation of synaptic plasticity.

The study of SNORD31A and its role in synaptic plasticity has led to the possibility that it may be a drug target or biomarker. Researchers have found that SNORD31A is expressed in the brain and is involved in the regulation of synaptic plasticity. They have also found that modulating SNORD31A activity may be a potential new way to treat neurological and psychiatric disorders.

One of the ways that SNORD31A is involved in synaptic plasticity is through its role in the regulation of the strengthening of neural connections, which is known as synaptic plasticity. SNORD31A is known to be involved in the regulation of the strengthening of connections between neurons, which is important for the formation of memories and the development of neural circuits.

Another way that SNORD31A is involved in synaptic plasticity is through its role in the regulation of the formation of new neurons.SNORD31A is known to be involved in the regulation of the production of new neurons, which is important for the growth and development of the brain.

In addition to its role in synaptic plasticity, SNORD31A is also thought to be involved in the regulation of other important processes in the brain, including the regulation of ion channels, neurotransmitter release, and cell signaling.

The study of SNORD31A and its role in synaptic plasticity has led to the possibility that it may be a drug target or biomarker. Researchers are currently studying the potential effects of modulating SNORD31A activity on neurological and psychiatric disorders. They are also exploring the use of SNORD31A as a potential drug target for the treatment of such disorders.

In conclusion, SNORD31A is a protein that is expressed in the brain and is known for its role in the regulation of synaptic plasticity. The study of SNORD31A and its role in synaptic plasticity has led to the possibility that it may be a drug target or biomarker. Further research is needed to fully understand the role of SNORD31A in synaptic plasticity and the potential uses of modulating its activity.

Protein Name: Small Nucleolar RNA, C/D Box 31

The "SNORD31 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD31 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets